Tumor immune microenvironment of EGFR-mutant non-small-cell lung cancer and its impact on therapeutic efficacy

被引：4
|
作者：
Matsumoto, Yoshiya [1 ,2 ]
Koh, Yasuhiro [2 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Dept Resp Med, Osaka, Japan
[2] Wakayama Med Univ, Internal Med 3, Wakayama, Japan
来源：
IMMUNOTHERAPY | 2020年 / 12卷 / 07期
关键词：
epidermal growth factor receptor; non-small-cell lung cancer; tumor microenvironment; tumor mutational burden; PD-L1; EXPRESSION; MUTATION INCIDENCE; OPEN-LABEL; PHASE IB; DOCETAXEL; NIVOLUMAB; ATEZOLIZUMAB; BLOCKADE; INFILTRATION; CHEMOTHERAPY;
D O I：
10.2217/imt-2019-0213
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：431 / 438
页数：8
相关论文
共 50 条
  • [41] AZD9291 in EGFR-mutant advanced non-small-cell lung cancer patients
    Remon, Jordi
    Planchard, David
    FUTURE ONCOLOGY, 2015, 11 (22) : 3069 - 3081
  • [42] Clinical Predictors of Response to EGFR Tyrosine Kinase inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
    Fukihara, Jun
    Watanabe, Naohiro
    Taniguchi, Hiroyuki
    Kondoh, Yasuhiro
    Kimura, Tomoki
    Kataoka, Kensuke
    Matsuda, Toshiaki
    Yokoyama, Toshiki
    Hasegawa, Yoshinori
    ONCOLOGY, 2014, 86 (02) : 86 - 93
  • [43] Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer
    Liu, Xiaoke
    Hong, Lingzhi
    Nilsson, Monique
    Hubert, Shawna Marie
    Wu, Shuhong
    Rinsurongkawong, Waree
    Lewis, Jeffery
    Spelman, Amy
    Roth, Jack
    Swisher, Steven
    He, Yong
    Lee, J. Jack
    Fang, Bingliang
    Heymach, John, V
    Zhang, Jianjun
    Le, Xiuning
    LUNG CANCER, 2020, 149 : 33 - 40
  • [44] Impact of Asian ethnicity on outcome in metastatic EGFR-mutant non-small cell lung cancer
    Gibson, Amanda J. W.
    D'Silva, Adrijana
    Elegbede, Anifat A.
    Tudor, Roxana A.
    Dean, Michelle L.
    Bebb, Dafydd Gwyn
    Hao, Desiree
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (06) : 343 - 352
  • [45] Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer
    Zhang, Shi-Ling
    Zhang, Chan -Yuan
    Chen, Yu-Qing
    Li, Yu -Fa
    Xie, Zhi
    Zhang, Xu-Chao
    Zhou, Qing
    Zhong, Wen-Zhao
    Huang, Jie
    Sun, Hao
    Zheng, Ming-Ying
    Xiao, Fa-Man
    Yan, Hong-Hong
    Lu, Dan-Xia
    Lv, Zhi-Yi
    Wu, Yi-Long
    Chen, Hua-Jun
    Yang, Jin-Ji
    JOURNAL OF THORACIC DISEASE, 2023, 15 (09) : 4620 - 4635
  • [46] New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis
    Shinohara, Shuichi
    Takahashi, Yusuke
    Komuro, Hiroyasu
    Matsui, Takuya
    Sugita, Yusuke
    Demachi-Okamura, Ayako
    Muraoka, Daisuke
    Takahara, Hirotomo
    Nakada, Takeo
    Sakakura, Noriaki
    Masago, Katsuhiro
    Miyai, Manami
    Nishida, Reina
    Shomura, Shin
    Shigematsu, Yoshiki
    Hatooka, Shunzo
    Sasano, Hajime
    Watanabe, Fumiaki
    Adachi, Katsutoshi
    Fujinaga, Kazuya
    Kaneda, Shinji
    Takao, Motoshi
    Ohtsuka, Takashi
    Yamaguchi, Rui
    Kuroda, Hiroaki
    Matsushita, Hirokazu
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (04)
  • [47] Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancer
    Liu, Xinyue
    Kong, Yan
    Qian, Youwen
    Guo, Haoyue
    Zhao, Lishu
    Wang, Hao
    Xu, Kandi
    Ye, Li
    Liu, Yujin
    Lu, Hui
    He, Yayi
    TRANSLATIONAL ONCOLOGY, 2024, 50
  • [48] Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients
    Gobbini, Elisa
    Toffart, Anne Claire
    Perol, Maurice
    Assie, Jean-Baptiste
    Duruisseaux, Michael
    Coupez, Dahna
    Dubos, Catherine
    Westeel, Virginie
    Delaunay, Myriam
    Guisier, Florian
    Veillon, Remi
    Gounant, Valerie
    Leprieur, Etienne Giroux
    Vanel, Francois-Roger
    Chaabane, Nouha
    Dansin, Eric
    Babey, Helene
    Decroisette, Chantal
    Barlesi, Fabrice
    Daniel, Catherine
    Fournel, Pierre
    Mezquita, Laura
    Oulkhouir, Youssef
    Canellas, Anthony
    Duchemann, Boris
    Molinier, Olivier
    Alcazer, Vincent
    Moro-Sibilot, Denis
    Levra, Matteo Giaj
    CLINICAL LUNG CANCER, 2020, 21 (05) : E497 - E510
  • [49] Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines
    Dal Maso, Alessandro
    Lorenzi, Martina
    Ferro, Alessandra
    Pilotto, Sara
    Cecere, Fabiana
    Follador, Alessandro
    Polo, Valentina
    Del Conte, Alessandro
    Sartori, Giulia
    Giavarra, Marco
    Scattolin, Daniela
    Indraccolo, Stefano
    Frega, Stefano
    De Maglio, Giovanna
    Menis, Jessica
    Bonanno, Laura
    Calabrese, Fiorella
    Guarneri, Valentina
    Conte, PierFranco
    Pasello, Giulia
    FUTURE ONCOLOGY, 2021, 17 (19) : 2513 - 2527
  • [50] Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives
    C Guven, Deniz
    Sahin, Taha K.
    Dizdar, Omer
    Kilickap, Saadettin
    BIOMARKERS IN MEDICINE, 2020, 14 (14) : 1383 - 1392
12345